Humacyte Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | -75.9% | -15.3% | +23.9% | -100.0% | – | – | |
| – | -28.5% | +13.4% | -86.5% | +827.3% | -90.6% | +137.1% | |
| – | – | – | – | – | – | – | |
| – | -28.5% | +13.4% | +3.1% | +21.0% | +15.7% | -21.8% | |
| – | -27.1% | +77.3% | +8.8% | +2.2% | +10.3% | +20.8% | |
| – | -26.2% | +75.9% | +268.6% | -69.8% | +356.3% | -13.8% | |
| – | – | – | – | – | – | – | |
| – | -4.2% | +97.5% | +42.6% | +6.4% | +40.6% | +21.3% | |
| – | – | – | – | – | – | – | |
| – | – | -3,007.0% | – | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | -4,045.1% | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.